Hollsteen
← Meta

D&A

Flow – sum over the period · $M

QuartersFiscal years

$MD&A · Q1 2016: $552M · 10-Q 0001326801-16-000067 filed Apr 28, 2016D&A · Q2 2016: $585M · derived · 10-Q 0001326801-17-000038 filed Jul 27, 2017D&A · Q3 2016: $591M · derived · 10-Q 0001326801-17-000053 filed Nov 2, 2017D&A · Q4 2016: $614M · derived · 10-K 0001326801-18-000009 filed Feb 1, 2018D&A · Q1 2017: $671M · 10-Q 0001326801-17-000024 filed May 4, 2017D&A · Q2 2017: $729M · derived · 10-Q 0001326801-18-000057 filed Jul 26, 2018D&A · Q3 2017: $772M · derived · 10-Q 0001326801-18-000067 filed Oct 31, 2018D&A · Q4 2017: $853M · derived · 10-K 0001326801-19-000009 filed Jan 31, 2019D&A · Q1 2018: $949M · 10-Q 0001326801-18-000032 filed Apr 26, 2018D&A · Q2 2018: $1.0B · derived · 10-Q 0001326801-19-000055 filed Jul 25, 2019D&A · Q3 2018: $1.1B · derived · 10-Q 0001326801-19-000069 filed Oct 31, 2019D&A · Q4 2018: $1.2B · derived · 10-K 0001326801-20-000013 filed Jan 30, 2020D&A · Q1 2019: $1.4B · 10-Q 0001326801-19-000037 filed Apr 25, 2019D&A · Q2 2019: $1.5B · derived · 10-Q 0001326801-20-000076 filed Jul 31, 2020D&A · Q3 2019: $1.4B · derived · 10-Q 0001326801-20-000084 filed Oct 30, 2020D&A · Q4 2019: $1.5B · derived · 10-K 0001326801-21-000014 filed Jan 28, 2021D&A · Q1 2020: $1.6B · 10-Q 0001326801-20-000048 filed Apr 30, 2020D&A · Q2 2020: $1.7B · derived · 10-Q 0001326801-21-000049 filed Jul 29, 2021D&A · Q3 2020: $1.7B · derived · 10-Q 0001326801-21-000065 filed Oct 26, 2021D&A · Q4 2020: $1.9B · derived · 10-K 0001326801-22-000018 filed Feb 3, 2022D&A · Q1 2021: $2.0B · 10-Q 0001326801-21-000033 filed Apr 29, 2021D&A · Q2 2021: $2.0B · derived · 10-Q 0001326801-22-000082 filed Jul 28, 2022D&A · Q3 2021: $2.0B · derived · 10-Q 0001326801-22-000108 filed Oct 27, 2022D&A · Q4 2021: $2.0B · derived · 10-K 0001326801-23-000013 filed Feb 2, 2023D&A · Q1 2022: $2.2B · 10-Q 0001326801-22-000057 filed Apr 28, 2022D&A · Q2 2022: $2.0B · derived · 10-Q 0001326801-23-000093 filed Jul 27, 2023D&A · Q3 2022: $2.2B · derived · 10-Q 0001326801-23-000103 filed Oct 26, 2023D&A · Q4 2022: $2.4B · derived · 10-K 0001326801-24-000012 filed Feb 2, 2024D&A · Q1 2023: $2.5B · 10-Q 0001326801-23-000067 filed Apr 27, 2023D&A · Q2 2023: $2.6B · derived · 10-Q 0001326801-24-000069 filed Aug 1, 2024D&A · Q3 2023: $2.9B · derived · 10-Q 0001326801-24-000081 filed Oct 31, 2024D&A · Q4 2023: $3.2B · derived · 10-K 0001326801-25-000017 filed Jan 30, 2025D&A · Q1 2024: $3.4B · 10-Q 0001326801-24-000049 filed Apr 25, 2024D&A · Q2 2024: $3.6B · derived · 10-Q 0001628280-25-036791 filed Jul 31, 2025D&A · Q3 2024: $4.0B · derived · 10-Q 0001628280-25-047240 filed Oct 30, 2025D&A · Q4 2024: $4.5B · derived · 10-K 0001628280-26-003942 filed Jan 29, 2026D&A · Q1 2025: $3.9B · 10-Q 0001326801-25-000054 filed May 1, 2025D&A · Q2 2025: $4.3B · derived · 10-Q 0001628280-26-050705 filed Jul 30, 2026D&A · Q3 2025: $5.0B · derived · 10-Q 0001628280-25-047240 filed Oct 30, 2025D&A · Q4 2025: $5.4B · derived · 10-K 0001628280-26-003942 filed Jan 29, 2026D&A · Q1 2026: $6.0B · 10-Q 0001628280-26-028526 filed Apr 30, 2026D&A · Q2 2026: $6.4B · derived · 10-Q 0001628280-26-050705 filed Jul 30, 20262,5246,356a552Q1 2016Q2 2026Q1 2023
$MD&A · Q1 2022: $2.2B · 10-Q 0001326801-22-000057 filed Apr 28, 2022D&A · Q2 2022: $2.0B · derived · 10-Q 0001326801-23-000093 filed Jul 27, 2023D&A · Q3 2022: $2.2B · derived · 10-Q 0001326801-23-000103 filed Oct 26, 2023D&A · Q4 2022: $2.4B · derived · 10-K 0001326801-24-000012 filed Feb 2, 2024D&A · Q1 2023: $2.5B · 10-Q 0001326801-23-000067 filed Apr 27, 2023D&A · Q2 2023: $2.6B · derived · 10-Q 0001326801-24-000069 filed Aug 1, 2024D&A · Q3 2023: $2.9B · derived · 10-Q 0001326801-24-000081 filed Oct 31, 2024D&A · Q4 2023: $3.2B · derived · 10-K 0001326801-25-000017 filed Jan 30, 20252,5243,172a2,156Q1 2022Q4 2023Q1 2023
Q1 2023
2,524$M
All values (42)
PeriodValue ($M)Status
Q2 20266,356derived
Q1 20265,999reported
Q4 20255,411derived
Q3 20254,963derived
Q2 20254,342derived
Q1 20253,900reported
Q4 20244,460derived
Q3 20244,027derived
Q2 20243,637derived
Q1 20243,374reported
Q4 20233,172derived
Q3 20232,859derived
Q2 20232,623derived
Q1 20232,524reported
Q4 20222,376derived
Q3 20222,175derived
Q2 20221,979derived
Q1 20222,156reported
Q4 20212,014derived
Q3 20211,995derived
Q2 20211,986derived
Q1 20211,972reported
Q4 20201,863derived
Q3 20201,698derived
Q2 20201,704derived
Q1 20201,597reported
Q4 20191,468derived
Q3 20191,416derived
Q2 20191,502derived
Q1 20191,355reported
Q4 20181,225derived
Q3 20181,107derived
Q2 20181,034derived
Q1 2018949reported
Q4 2017853derived
Q3 2017772derived
Q2 2017729derived
Q1 2017671reported
Q4 2016614derived
Q3 2016591derived
Q2 2016585derived
Q1 2016552reported

CSV with all sources · Technical ID: dna

More metrics for Meta

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Operating income by segment

Sources & calculation
Value
$2.5B
Period
Q1 2023, ended Mar 31, 2023 · quarterly value (3 months, not cumulative)
Source
10-Q, filed Apr 27, 2023 · 0001326801-23-000067
Location
us-gaap:DepreciationDepletionAndAmortization
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$2.5BApr 27, 202310-Q 0001326801-23-000067reported · confidence 1. · current